{
  "id": "lymphoma-resource-by-category",
  "display_name": "Lymphoma Resource by Category",
  "cohort": "DLBCL and FL Resource Utilization by Category (2024â€“2025)",
  "insight_type": "Category-Based Resource Analysis",
  "summary": "Growth factor usage exceeds benchmarks by 185%, while infection prophylaxis is 42% below benchmarks. Antiemetic usage is also 73% above expected, indicating resource misallocation.",
  "chart": {
    "type": "bar",
    "unit": "category",
    "data": [
      { "name": "Growth Factors", "value": 285, "gap": 185, "highlight": true },
      { "name": "Antiemetics", "value": 173, "gap": 73, "highlight": true },
      { "name": "Hydration", "value": 124, "gap": 24, "highlight": false },
      { "name": "Pain Management", "value": 91, "gap": -9, "highlight": false },
      { "name": "Infection Prophylaxis", "value": 58, "gap": -42, "highlight": true }
    ],
    "benchmark": 100,
    "nccn_target": 90
  },
  "financial_impact": {
    "annual_opportunity": "$295,000/year",
    "math": "$295,000/year = ($215,000 G-CSF reduction + $125,000 antiemetic optimization - $45,000 prophylaxis increase)"
  },
  "clinical_impact": {
    "description": "Optimizing resource allocation across categories can improve outcomes while reducing costs.",
    "metrics": [
      {
        "type": "FN",
        "value": "-8%",
        "description": "Only minor increase in febrile neutropenia with optimized G-CSF"
      },
      {
        "type": "Inf",
        "value": "-44%",
        "description": "Potential reduction in infections with prophylaxis optimization"
      },
      {
        "type": "CINV",
        "value": "+5%",
        "description": "Minimal increase in CINV with optimized antiemetic protocols"
      },
      {
        "type": "Hosp",
        "value": "-28%",
        "description": "Reduction in hospitalization with balanced approach"
      },
      {
        "type": "QoL",
        "value": "+18%",
        "description": "Improved quality of life with optimized supportive care"
      }
    ],
    "quantitative": "-44% infections"
  },
  "peer_comparison": {
    "description": "Top-performing lymphoma centers use G-CSF in only 135% of benchmark cases vs. your 285%, while maintaining infection prophylaxis at 92% vs. your 58%, resulting in better outcomes at lower costs.",
    "peer_benchmark": 135,
    "financial_impact": {
      "annual_opportunity": "$385,000/year",
      "math": "$385,000/year = ($285,000 G-CSF reduction + $155,000 antiemetic optimization - $55,000 prophylaxis increase)"
    },
    "action_steps": [
      {
        "text": "Implement G-CSF risk-based protocol",
        "icon": "document"
      },
      {
        "text": "Create antiemetic pathway based on emetogenic risk",
        "icon": "document"
      },
      {
        "text": "Develop infection risk assessment tool",
        "icon": "chart"
      },
      {
        "text": "Establish supportive care medication review process",
        "icon": "clipboard"
      }
    ]
  },
  "weighted_score": 95,
  "action_steps": [
    {
      "text": "Implement G-CSF restriction protocol for low-risk patients",
      "icon": "document"
    },
    {
      "text": "Create antiemetic stewardship program",
      "icon": "clipboard"
    },
    {
      "text": "Develop infection prophylaxis risk assessment",
      "icon": "chart-line"
    },
    {
      "text": "Establish resource utilization dashboard by category",
      "icon": "chart"
    }
  ],
  "suggestions": [
    {
      "text": "Consider pharmacy-led supportive care optimization program",
      "icon": "users"
    },
    {
      "text": "Implement cost-effectiveness analysis by category",
      "icon": "chart-line"
    }
  ],
  "drilldowns": [
    {
      "label": "View by Phase",
      "cohort": "Lymphoma Resource Utilization by Treatment Phase",
      "jsonFile": "lymphoma-resource-by-phase.json",
      "drilldownLevel": 1
    },
    {
      "label": "View by Provider",
      "cohort": "Lymphoma Resource Utilization by Provider",
      "jsonFile": "lymphoma-resource-by-provider.json",
      "drilldownLevel": 1
    },
    {
      "label": "View Overview",
      "cohort": "Lymphoma Resource Allocation",
      "jsonFile": "lymphoma-resource-allocation.json",
      "drilldownLevel": 0
    }
  ]
} 